4th Quarter - Report

GILEAD SCIENCES, INC. for GILEAD SCIENCES INC

Firm
Client
Income
—
Expenses
$400,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Domestic HIV Policy issues: HIV/AIDS Technology Transfer and Patent Rights; HIV Testing and Treatment; Federal Employees Health Benefits and Program Coverage for Routine HIV screening; HIV/AIDS Funding. Health Care Reform ( Patient Protection and Affordable Care Act - P.L.111-148; Health Care and Education Affordability Reconciliation Act - P.L.111-152); Hepatitis B Funding for Screening and Linkage to Care Programs; Medicare Part D and Dual Eligibles; International HIV and Health issues; International Trade and Intellectual Property Rights issues.

LobbyistCovered position, as disclosed
JOSEPH GROGAN New Exec.Dir.Presidential Advisory Council HIV/AIDS
CRISTIN LIS —
REKHA RAMESH —

Contacted: HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); SENATE; U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Veterans Affairs, Dept of (VA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.